Lecturer in Physiotherapy 👨🏼🏫//
Physiotherapist MSK Pain 🏋️♂️ //
Innsbruck, Austria 🏔️
🤔 Be cautious with positive A vs. A+B results.
🧩 Use credible, similar sham controls in trials.
🚫 Positive A vs. A+B results ≠ evidence of efficacy — no drug would be approved with that design. (i had to argue here with a reviewer in another journal...)
🤔 Be cautious with positive A vs. A+B results.
🧩 Use credible, similar sham controls in trials.
🚫 Positive A vs. A+B results ≠ evidence of efficacy — no drug would be approved with that design. (i had to argue here with a reviewer in another journal...)
📉 Only 3/16 studies showed mid-term effects (and few even measured follow-up).
⏱️ 50% found short-term significance, but < half were clinically relevant.
🧪 Weaker studies: 85% positive vs. 50% in stronger ones.
⚠️ Many used non-guideline control treatments.
📉 Only 3/16 studies showed mid-term effects (and few even measured follow-up).
⏱️ 50% found short-term significance, but < half were clinically relevant.
🧪 Weaker studies: 85% positive vs. 50% in stronger ones.
⚠️ Many used non-guideline control treatments.
Our hypothesis: Short-term effects yes, long-term none.
Our hypothesis: Short-term effects yes, long-term none.
PainScience.com/placebo_power_hype
PainScience.com/placebo_power_hype